Anticoagulation of mechanical valve prosthese: The difficult situations;Anticoagulation des prothèses valvulaires mécaniques: Les situations difficiles

Archives des Maladies du Coeur et des Vaisseaux

Volumn 94, Issue 11 SUPPL., 2001, Pages 1285-1290

  Roudaut, R ^a   Roudaut, M F ^a   Labeque J N ^a   Perron, J M ^a   Lafitte, S ^a   Jais C ^a   Zabsonre P ^a   Coste, P ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

ANTICOAGULATION; ARTICLE; BLEEDING; CARDITIS; CLINICAL PROTOCOL; EMBRYOPATHY; HEART VALVE PROSTHESIS; HUMAN; POSTOPERATIVE PERIOD; PREGNANCY; THROMBOEMBOLISM;

ANTICOAGULANTS; ENDOCARDITIS, BACTERIAL; FEMALE; HEART VALVE PROSTHESIS; HEMORRHAGE; HEPARIN; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS; THROMBOEMBOLISM; THROMBOSIS;

EID: 0012966717     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves
2. Adjusting anticoagulation to prosthesis thrombogenicity and patient risk factors. Recommendations for the Medtronic Hall valve
3. German experience with low intensity anticoagulation (GELIA): Protocol of a multi-center randomized, prospective study with the St. Jude Medical Valve
4. AREVA: Multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves
5. Randomized comparisen of moderate (INR 2.0 - 3.5) with low intensity (INR 2.0 - 3.5) anticoagulant therapy in patients with prosthetic heart valves treated by aspirin (100 mg/day)
6. Guidelines for prevention of thromboemblic events in valvular heart disease
7. rd ed.
8. Guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease)
9. Recommandations de la société française de cardiologie concernant les indications et la surveillance du traitement anticoagulant oral
10. Anticoagulation in valvular heart disease: New aspects and management during non-cardiac surgery
11. Echocardiographie transoesophagienne systématique dans les 24 premières heures postopératoires après remplacement valvulaire mitral
12. Small Abnormal echos after mitral valve replacement with bileaflet mechanical prostheses: Predisposing factors and effect on thromboembolism
13. Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude Medical Prosthesis
14. Anticoagulation and prosthetic heart valves
15. Low molecular weight heparin after mechanical heart valve replacement
16. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses
17. The management of anticoagulation during non cardiac operations in patients with prosthetic heart valves
18. Perioperative bleeding and thromboembolic risk during non cardiac surgery in patients with mechanical prosthetic heart valves: An institutional review
19. Anticoagulant management of patients with mechanical prosthetic valves undergoing non cardiac surgery. Indictions and unresolved issues
20. Modern management of prosthetic valve anticoagulation
21. Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery
22. Dental surgery in anticoagulated patients
23. Simple and safe method to prepare patients with prosthetic heart valves for surgical dental procedure
24. Preoperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: An institutional review
25. Use of enoxaparine for the chronically anticoagulated patient before and after procedures
26. Outpatients anticoagulation protocol for mechanical valve recipients undergoing non-cardiac surgery
27. Is low-molecular-weight heparin a safe alternative to unfractionated heparin in patients with prosthetic mechanical heart valves who must interrupt antithrombotic therapy?
28. Grossesses chez les porteuses de prothèses valvulaires. Etude coopérative rétrospective française (155 cas)
29. Anticoagulation in pregnant women with mechanical heart valve prostheses
30. Dose-dependent fetal complications of Warfarin in pregnant women with mechanical heart valves
31. Use of antithrombotic agents during pregnancy
32. Anticoagulation of pregnant women with mechanical heart valves
33. Pregnancy through a prosthetic heart valve
34. Effects of dipyridamole in combination with anticoagulant therapy in survival and thromboembolic events in patients with prosthetic heart valves
35. The dilemma of discontinuation therapy for patients with intracranial hemorrhage and mechanical heart valves
36. Restarting anticoagulation in prosthetic heart valve patients after intracranial hemorrhage: A 2-years follow-up
37. The risk of with-drawing chronic anticoagulation because of acute gastrointestinal bleeding
38. How safety and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage